Journal article
The safety of treating newly diagnosed epilepsy
S Sharma, P Kwan
Expert Opinion on Drug Safety | TAYLOR & FRANCIS LTD | Published : 2019
Abstract
Introduction: Epilepsy is a serious chronic neurological disorder manifested by an enduring symptomatic predisposition to seizures. Newly diagnosed individuals face increased morbidity, mortality, and socioeconomic costs. Anti-epileptic drug therapy is the treatment usually prescribed, which has efficacy in seizure control and mitigating long-term mortality. Areas covered: Safety of anti-epileptic drug therapy in adults with a focus in newly diagnosed patients. Areas covered include the most commonly experienced adverse drug effects, as well as those with the highest impacts on drug tolerability, quality of life, morbidity and mortality. Evidence was also reviewed to identify clinical strate..
View full abstractGrants
Awarded by Eisai
Funding Acknowledgements
P Kwan is supported by the Medical Research Future Fund Practitioner Fellowship (APP1136427).